A clinical solution for non‐toxic 3D‐printed photon blocks in external beam radiation therapy
Journal of Applied Clinical Medical Physics · 2024
DOI: 10.1002/acm2.14225 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Clinical Medical Physics, 2024. Verfasst von Joseph B Schulz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, School of Medicine, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: Tungsten, Radiation Protection. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
A well‐known limitation of multi‐leaf collimators is that they cannot easily form island blocks. This can be important in mantle region therapy. Cerrobend photon blocks, currently used for supplementary shielding, are labor‐intensive and error‐prone. To address this, an innovative, non‐toxic, automatically manufactured photon block using 3D‐printing technology is proposed, offering a patient‐specific and accurate alternative. Methods and materials The study investigates the development of patient‐specific photon shielding blocks using 3D‐printing for three different patient cases. A 3D‐printed photon block shell filled with tungsten ball bearings (BBs) was designed to have similar dosimetric properties to Cerrobend standards. The generation of the blocks was automated using the Eclipse Scripting API and Python. Quality assurance was performed by comparing the expected and actual weight of the tungsten BBs used for shielding. Dosimetric and field geometry comparisons were conducted between 3D‐printed and Cerrobend blocks, utilizing ionization chambers, imaging, and field geometry analysis.
Results
The quality assurance assessment revealed a −1.3% average difference in the mass of tungsten ball bearings for different patients. Relative dose output measurements for three patient‐specific blocks in the blocked region agreed within 2% of each other. Against the Treatment Planning System (TPS), both 3D‐printed and Cerrobend blocks agreed within 2%. For each patient, 6 MV image profiles taken through the 3D‐printed and Cerrobend blocks agreed within 1% outside high gradient regions. Jaccard distance analysis of the MV images against the TPS planned images, found Cerrobend blocks to have 15.7% dissimilarity to the TPS, while that of the 3D‐printed blocks was 6.7%.
Conclusions
This study validates a novel, efficient 3D‐printing method for photon block creation in clinical settings. Despite potential limitations, the benefits include reduced manual labor, automated processes, and greater precision. It holds potential for widespread adoption in radiation therapy, furthering non‐toxic radiation shielding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, School of Medicine, Stanford University, Stanford, California, USA.
ORCID-Profile: Joseph B Schulz, Piotr Dubrowski, Amy S Yu, Lawrie Basil Skinner
Zitieren
APA
Schulz, J. B., Dubrowski, P., Gibson, C., Yu, A. S., & Skinner, L. B. (2024). A clinical solution for non‐toxic 3D‐printed photon blocks in external beam radiation therapy. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.14225
Vancouver
Schulz JB, Dubrowski P, Gibson C, Yu AS, Skinner LB. A clinical solution for non‐toxic 3D‐printed photon blocks in external beam radiation therapy. Journal of Applied Clinical Medical Physics. 2024. doi:10.1002/acm2.14225
BibTeX
@article{Schulz2024,
author = {Schulz, Joseph B and Dubrowski, Piotr and Gibson, Clinton and Yu, Amy S and Skinner, Lawrie Basil},
title = {A clinical solution for non‐toxic 3D‐printed photon blocks in external beam radiation therapy},
journal = {Journal of Applied Clinical Medical Physics},
year = {2024},
doi = {10.1002/acm2.14225}
}
EUVIMED